Bottom line
LHCSX vs PHSYX: the short answer
LHCSX (Lord Abbett Health Care Fund) and PHSYX (Putnam Global Health Care Fund) are both mutual funds.
PHSYX is cheaper at 0.79% vs 1.03% — a difference of $24 a year per $10,000 invested.
Over five years, PHSYX returned +8.1% a year vs +4.3% for LHCSX (reporting dates differ).
Updated Nov 19, 2026
LHCSX vs PHSYX side by side
| LHCSX | PHSYX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Lord Abbett | Franklin Templeton |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.03% | 0.79% |
| Annual cost per $10k | $103 | $79 |
| 10-yr cost on $10k (prospectus) | $3,593 | $978 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +17.7% | +1.5% |
| 5-yr return (annualized) | +4.3% | +8.1% |
| 10-yr return (annualized) | — | +7.8% |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $8.6M | $1.5B |
| Number of holdings | 61 | 115 |
| Portfolio turnover | 91% | 67% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of LHCSX's top 25 holdings also appear in PHSYX's top 25.
| Holding | LHCSX | PHSYX |
|---|---|---|
| Eli Lilly & Co | 10.40% | 13.15% |
| UnitedHealth Group Inc | 5.39% | 6.93% |
| Johnson & Johnson | 4.96% | 8.46% |
| Novartis AG | 4.19% | 5.13% |
| Gilead Sciences Inc | 3.53% | 2.63% |
| CVS Health Corp | 3.33% | 2.74% |
| Thermo Fisher Scientific Inc | 2.31% | 4.50% |
| Vertex Pharmaceuticals Inc | 2.24% | 1.97% |
| AstraZeneca PLC | 1.97% | 4.67% |
| Edwards Lifesciences Corp | 1.78% | 2.80% |
Source: SEC Form N-PORT
LHCSX top 10
- Eli Lilly & Co — 10.40%
- UnitedHealth Group Inc — 5.39%
- Johnson & Johnson — 4.96%
- Novartis AG — 4.19%
- Natera Inc — 3.60%
- Gilead Sciences Inc — 3.53%
- CVS Health Corp — 3.33%
- Guardant Health Inc — 2.61%
- Galderma Group AG — 2.60%
- Thermo Fisher Scientific Inc — 2.31%
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
FAQ
What is the difference between LHCSX and PHSYX?
LHCSX (Lord Abbett Health Care Fund) and PHSYX (Putnam Global Health Care Fund) are both mutual funds. PHSYX is cheaper at 0.79% vs 1.03% — a difference of $24 a year per $10,000 invested.
Which is cheaper, LHCSX or PHSYX?
PHSYX has the lower expense ratio (0.79%).
Should I own both LHCSX and PHSYX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.